Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 26.
doi: 10.1007/s13258-025-01714-y. Online ahead of print.

MicroRNA-124 induces AML differentiation and apoptosis through c-Myc suppression

Affiliations

MicroRNA-124 induces AML differentiation and apoptosis through c-Myc suppression

Byeol-Eun Jeon et al. Genes Genomics. .

Abstract

Background: Acute myeloid leukemia (AML) is a hematologic malignancy marked by blocked differentiation and uncontrolled proliferation. While miR-124 has been implicated as a tumor suppressor in various cancers, its functional role in AML remains unclear.

Objective: This study aimed to investigate the anti-leukemic effects of miR-124 and its regulatory mechanisms involving c-Myc and ROS signaling in AML.

Methods: AML cells were engineered to overexpress miR-124. Functional assays including flow cytometry, viability, and apoptosis analyses were conducted. ROS levels were measured, and c-Myc regulation was evaluated via western blotting, qPCR, ChIP, and pharmacological inhibition. Exosome-mediated delivery was also examined.

Results: miR-124 overexpression induced AML cell differentiation and apoptosis, accompanied by ROS accumulation and c-Myc downregulation. ROS induction suppressed c-Myc and activated the p21/p16/Rb axis, promoting cell cycle arrest. ChIP assays revealed that c-Myc binds the miR-124 promoter, indicating a negative feedback loop. Combination treatment with miR-124 and a c-Myc inhibitor enhanced anti-proliferative effects. Additionally, miR-124-containing exosomes reduced AML cell viability.

Conclusions: miR-124 acts as a tumor suppressor in AML by modulating a ROS-dependent c-Myc signaling pathway and inducing differentiation and apoptosis. These findings highlight miR-124 as a promising therapeutic and prognostic target in AML.

Keywords: AML differentiation; Acute myeloid leukemia; MicroRNA-124; Reactive oxygen species (ROS); c-Myc.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors confirm that they have no conflicts of interest. Ethical approval: Not applicable. Informed consent: Not applicable.

References

    1. Aljitawi OS, Li D, Xiao Y, Zhang D, Ramachandran K, Stehno-Bittel L, Van Veldhuizen P, Lin TL, Kambhampati S, Garimella R (2014) A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells. Leuk Lymphoma 55:378–391 - DOI - PubMed
    1. An L, Liu Y, Wu A, Guan Y (2013) MicroRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS ONE 8:e69478 - DOI - PubMed - PMC
    1. Bakker E, Qattan M, Mutti L, Demonacos C, Krstic-Demonacos M (2016) The role of microenvironment and immunity in drug response in leukemia. Biochim Biophys Acta (BBA) Mole Cell Res 1863:414–426 - DOI
    1. Chen J, Odenike O, Rowley JD (2010) Leukaemogenesis: more than mutant genes. Nat Rev Cancer 10:23–36 - DOI - PubMed - PMC
    1. Chou J, Shahi P, Werb Z (2013) microRNA-mediated regulation of the tumor microenvironment. Cell Cycle 12:3262–3271 - DOI - PubMed - PMC